DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,851,330 | +1152.1% | 599,469 | +672.1% | 0.00% | – |
| Q1 2023 | $2,224,300 | -15.2% | 77,637 | -7.6% | 0.00% | – |
| Q4 2022 | $2,621,581 | +240.0% | 84,025 | +120.8% | 0.00% | – |
| Q3 2022 | $771,000 | +54.2% | 38,057 | +18.1% | 0.00% | – |
| Q2 2022 | $500,000 | +880.4% | 32,220 | +1105.4% | 0.00% | – |
| Q1 2022 | $51,000 | -93.8% | 2,673 | -91.8% | 0.00% | – |
| Q4 2021 | $823,000 | – | 32,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $62,993,000 | 33.95% |
| Sands Capital Ventures, LLC | 3,148,970 | $60,240,000 | 12.58% |
| OUP Management Co., LLC | 536,693 | $10,267,000 | 7.82% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $10,650,000 | 5.25% |
| Logos Global Management LP | 1,385,251 | $26,500,000 | 3.44% |
| Soleus Capital Management, L.P. | 983,994 | $18,824,000 | 2.43% |
| RA Capital Management | 5,208,911 | $99,646,000 | 2.17% |
| Deep Track Capital, LP | 1,250,000 | $23,913,000 | 1.53% |
| Samsara BioCapital, LLC | 228,466 | $4,371,000 | 1.10% |
| HighVista Strategies LLC | 48,960 | $937,000 | 0.60% |